Global Malaria Vaccine Market Report by Product, by Distribution Channel, by Gender, & by Region with Forecast 2017-2030

Market Overview

As per WHO, nearly 50% of the global population is at the risk of malaria, there were 214 million malaria cases reported in 2015. In 2012, more than 24 active malaria vaccine candidates were in clinical development and more than 12 were in preclinical development where majority of the candidate targeted Plasmodium falciparum and blood & pre-erythrocytic stages of malaria.

The WHO has introduced a Global Technical Strategy for Malaria 2017-2030 (GTS) in 2015 with specific goals, one of them is focused at eliminating malaria from at least 10 countries. Indian government has introduced Drug Distribution Centers (DDCs) and Fever Treatment Depots (FTDs) in the rural areas for providing easy access to anti-malarial medicines. Many government initiatives like in 2017 GSK announced plans to develop vaccine at profit margin of 5% of the cost of vaccine.

Global Malaria Vaccine Market Segmentation

• By Vaccine Type

  • Pre-Erythrocytic Vaccine

  • Erythrocytic Vaccine

  • Multi-Antigen Vaccine

• By Agent

• Plasmodium Falciparum

• Plasmodium Vivax

• By End Users

• Hospital/Labs

• Community Centers

• Others (retail pharmacies, online pharmacies, etc)

• By Region

  • North America (U.S. & Canada) {Market Size (USD Billion), Growth Analysis (%) and Adoption Rate (%)}

  •  Latin America (Brazil, Mexico & Rest of Latin America)         {Market Size (USD Billion), Growth Analysis (%) and Adoption Rate (%)}

  • Europe (The U.K., Germany, France, Italy, Spain, Poland, Sweden & RoE) {Market Size (USD Billion), Growth Analysis (%) and Adoption Rate (%)}

  • Asia-Pacific (China, India, Japan, Singapore, South Korea, Australia, New Zealand, Rest of Asia) {Market Size (USD Billion), Growth Analysis (%) and Adoption Rate (%)}

  • Middle East & Africa (GCC, South Africa, North Africa, RoMEA) {Market Size (USD Billion), Growth Analysis (%) and Adoption Rate (%)}

  •  Rest of World {Market Size (USD Billion), Growth Analysis (%) and Adoption Rate (%)}

Market Size and Forecast (2017-2030)

Global malaria vaccines market is expected to witness a modest CAGR during the forecast period (2017 – 2030).

The P. falciparum vaccines market is among the dominating vaccine candidates targeting malaria parasite. India accounts for 60-70% of the total incidence rate in South-East Asia. Community centers dominate the end user segment in terms of revenue generation as demand for preventive treatments is high among others like hospitals, labs, NGO’s, etc.

Drivers and Challenge to Growth Market

The malaria parasite has a very complex lifecycle and no vaccine is approved for human use. Increasing accessibility along with government support, artemisinin and P.falciparum resistance i.e. the most available anti malaria vaccine, rural population resides in malaria endemic areas and tourism from low incidence rate of malaria are identified as the most susceptible target population for malaria tends to drive the global malaria vaccine market. Regular monitoring, R&D programs on malaria and surveillance by various government programs will drive global malaria vaccines market growth during the forecast period.

Limited financial returns, little attraction for private commercial sectors and mosquito repellent products (patches, creams, coils, mats, liquids, etc.) tends to hinder the global malaria vaccine market.

Key Market Players

• Sanaria Inc

• Synopsis

• Business Strategy

• Product Portfolio

• SWOT Analysis

• Nobelpharma Co.

• Sumaya Biotech

• Glaxosmithkline

• GenVec Inc.

Covered in this Global Malaria Vaccine Market Report

Market Synopsis

Market Segmentation

The Global Malaria Vaccine Market is segmented as follows:

• By Vaccine Type (Market Size, Demand Analysis and Growth Analysis)

• By Agent (Market Size, Demand Analysis and Growth Analysis)

• By End-User (Market Size, Demand Analysis and Growth Analysis)

By Regions

• North America (U.S., Canada) {Market Size, Growth Analysis and Opportunity Analysis}

• Latin America (Argentina, Mexico, Brazil and Rest of Latin America) {Market Size, Growth Analysis and Opportunity Analysis}

• Europe (Germany, Italy, Spain, France, The U.K., Netherlands, Sweden, Hungary, Russia, Poland, Rest of Europe) {Market Size, Growth Analysis and Opportunity Analysis}

• Asia-Pacific (China, India, Singapore, Japan, Hong-Kong, Australia, New Zealand, South Korea and Rest of Asia Pacific) {Market Size, Growth Analysis and Opportunity Analysis}

• Middle East and North Africa (MENA) {Market Size, Growth Analysis and Opportunity Analysis}

• Rest of World  {Market Size, Growth Analysis and Opportunity Analysis}

Market Dynamics: Growth Drivers, Restraints and Opportunities

• Risk Factors

• Regional Variations

• Recent Trends and Developments

Key Market Players

• Synopsis

• Business Strategy

• Product Portfolio

• SWOT Analysis

Porter’s Five Force Model

Market Landscape: Competition and Beyond

Market outlook for business players and entry level players to ascertain their business in dynamic ecosystem

Expert Analysis

Concluding Remarks